Companies in the biopharma sector developing innovative solutions and technologies.
Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.
ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.
Federated Biologics is a biotechnology company that develops treatment drugs through cell culture manufacturing.
Modicus Prime enables pharmaceutical manufacturers to deploy AI systems that are auditable and compliant by design.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.
Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.
Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
Locksmith Bio is a biotechnology company that uses AI to map intrinsically disordered protein for novel drug discovery.
CancerVAX Biotech is a biotechnology company that develops universal cancer treatment using the body’s immune system.
BioOrbit is a space manufacturing firm that develops hardware for large-scale protein drug crystallization.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.
Entelo bio is a computational biotech company building the engine for functional cell profiling and novel target discovery.
DIANA Biotechnologies specializes in the development of products based on research in clinical diagnostics and drug discovery areas.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.
BiomeBank is a clinical stage biotechnology company developing microbial therapies
Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.
Aletira is an emerging biotechnology company based on technologies created at Johns Hopkins University.
Enjamb Labs is an AI platform that streamlines drug development, clinical research, and regulatory processes for biopharma teams.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked